Cutaneous deposits

American Journal of Dermatopathology

Volumn 36, Issue 1, 2014, Pages 1-48

  Molina Ruiz, Ana M ^a   Cerroni, Lorenzo ^b   Kutzner, Heinz ^c   Requena, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Dermatophatologische   (Germany)

Author keywords

cutaneous deposits; deposition disorders; histopathology

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; AMIODARONE; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CALCIUM SALT; CARMUSTINE; CHLORMETHINE; CISPLATIN; CLOFAZIMINE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; GLASS FIBER; HEAVY METAL; HEMOSIDERIN; HEPARIN CALCIUM; HYALIN; HYDROXYAPATITE; METAL; OXALIC ACID; PHENOTHIAZINE DERIVATIVE; PIGMENT; POLYACRYLAMIDE; POLYLACTIC ACID; POVIDONE; SILICONE; TETRACYCLINE DERIVATIVE;

ALBRIGHT SYNDROME; AMYLOIDOSIS; ARTICLE; BONE; CALCINOSIS; CARTILAGE; CHONDROCALCINOSIS; CHONDROMA; CHRYSIASIS; COLLOID; CONNECTIVE TISSUE DISEASE; CRYSTAL; CUTANEOUS DEPOSITION DISORDER; DERMATOMYOSITIS; DERMIS; FIBROUS DYSPLASIA; GENODERMATOSIS; GOUT; HEMOCHROMATOSIS; HERPES SIMPLEX; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LIPOID PROTEINOSIS; LUPUS VULGARIS; METABOLIC DISORDER; MYOSPHERULOSIS; NONHUMAN; OCHRONOSIS; OSTEOMA; PANNICULITIS; PILOMATRIXOMA; PORPHYRIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; PSEUDOXANTHOMA ELASTICUM; SKIN CALCIFICATION; SKIN DISEASE; STORAGE DISEASE; SUBCUTANEOUS TISSUE; TATTOO; TUMOR CALCINOSIS; WERNER SYNDROME;

HUMANS; SKIN DISEASES;

EID: 84893794367     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182740122     Document Type: Article

References (360)

1. Walsh JS, Fairley JA. Calcifying disorders of the skin. J Am Acad Dermatol. 1995;33:693-706.
2. Touart DM, Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol. 1998;39:527-544.
3. Reiter N, El-Shabrawi L, Leinweber B, et al. Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol. 2011;65:1-12.
4. Weedon D. Cutaneous deposits. In: Weedon D, ed. Weedonis Skin Pathology. China: Elsevier; 2010:370-396.
5. Pugashetti R, Shinkai K, Ruben BS, et al. Calcium may preferentially deposit in areas of elastic tissue damage. J Am Acad Dermatol. 2011;64:296-301.
6. Sultan-Bichat N, Menard J, Perceau G, et al. Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol. 2012;66:424-429.
7. Raimer SS. Calcinosis cutis. Curr Concept Skin Disord. 1985;6:9-15.
8. Velayos EE, Masi AT, Stevens MB, et al. The CREST syndrome: comparison with systemic sclerosis (scleroderma). Arch Intern Med. 1979;39:1240-1244.
9. Hazen PG, Askari A. Localized scleroderma with cutaneous calcinosis. A distinctive variant. Arch Dermatol. 1979;115:871-872.
10. Sallum A, Pivato F, Doria-Filho U, et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr (Rio J). 2008;84:68-74.
11. Bowyer SL, Blane CE, Sullivan DB, et al. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr. 1983;103:882-888.
12. Ichiki Y, Akiyama T, Shimozawa N, et al. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol. 2001;144:894-897.
13. Rothe MJ, Grant-Kels JM, Rothfield NF. Extensive calcinosis cutis with systemic lupus erythematosus. Arch Dermatol. 1990;126:1060-1063.
14. Carette S, Urowitz MB. Systemic lupus erythematosus and diffuse soft tissue calcification. J Dermatol. 1983;22:416-418.
15. Wilson PR. Porphyria cutanea tarda with cutaneous "scleroderma" and calcification. Australas J Dermatol. 1985;30:93-96.
16. Federico A, Weinel S, Fabre V, et al. Dystrophic calcinosis cutis in pseudoxanthoma elasticum. J Am Acad Dermatol. 2008;58:707-710.
17. Murata K, Nakashima H. Werner's syndrome: twenty-four cases and review of the Japanese medical literature. J Am Geriatr Soc. 1982;30:303-308.
18. Proske S, Hartschuh W, Enk A, et al. Ehlers Danlos Syndrom-20 Jahre Erfahrungen in Diagnostik und Klassifikation an der Universi-tats-Hautklinik Heidelberg. J Dtsch Dermatol Ges. 2006;4:308-318.
19. Yamamoto O, Hamada T, Doi Y, et al. Immunohistochemical and ultrastructural observations of desmoplastic trichoepithelioma with a special reference to a morphological comparison with normal apocrine acrosyringeum. J Cutan Pathol. 2002;29:15-26.
20. Leppard BJ, Sanderson KB. The natural history of trichilemmal cysts. Br J Dermatol. 1976;94:379-390.
21. Browne SG. Calcinosis circumscripta of the scrotal wall: the etiological role of Onchocerca volvulus. Br J Dermato1. 1962;74:136-140.
22. Pastel A, Grupper C. Subcutaneous calcification, generalized calcinosis in nodular chains: cysticercosis. Bull Sot Fr Dermatol Syphiligr. 1969; 76:28-31.
23. Beers BB, Flowers FP, Sherertz EF, et al. Dystrophic calcinosis cutis secondary to intrauterine herpes simplex. Pediatr Dermatol. 1986;3: 208-211.
24. Oga A, Kadowaki T, Hamanaka S, et al. Dystrophic calcinosis cutis in the skin below the mandible of a violinist. Br J Dermatol. 1998;139:940-941.
25. Domínguez-Fernández I, Goíriz R, Pérez-Gala S, et al. Calcinosis cutis following extravasation of calcium salts. J Eur Acad Dermatol Venereol 2008;22:505-506.
26. Eich D, Scharffetter-Kochanek K, Weihrauch J, et al. Calcinosis of the cutis and subcutis: an unusual nonimmunologic adverse reaction to subcutaneous injections of low-molecular-weight calcium-containing heparins. J Am Acad Dermatol. 2004;50:210-214.
27. Boccara O, Prost-Squarcioni C, Battistella M, et al. Calcinosis cutis. A rare reaction to subcutaneous injections of calcium-containing heparin in patients with renal failure. Am JDermatopathol. 2010;32:52-55.
28. Clarke JT, Clarke LE, Miller JJ. Petrified ears: calcification of the auricular cartilage. J Am Acad Dermatol. 2004;51:799-800.
29. Requena L, Sánchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45:325-361.
30. Wilson CW, Wingfield WL, Toone EC. Vitamin D poisoning with metastatic calcification. Am J Med. 1953;14:116-123.
31. Goldsmith DJ. Milk-alkali syndrome with metastatic calcification. Am J Med. 1996;100:481-482.
32. Lathan SR, Block RA, McLean RL. Sarcoidosis with "metastatic" calcification. Am J Med. 1968;44:1000-1004.
33. Hewitt M, Chambers TL. Early presentation of pseudohypoparathyroidism. J R Sot Med. 1988;81:666-667.
34. Lateo S, Charlton F, Hudson M, et al. Cutaneous calcification following liver transplantation. Clin Exp Dermatol. 2005;30:484-486.
35. Friedman JS, Walters RF, Woosley J, et al. A unique presentation of calcinosis cutis in a patient with cystic fibrosis after double lung transplants. J Am Acad Dermatol. 2003;49:1131-1136.
36. Oh DH, Eulau D, Tokugawa DA, et al. Five cases of calciphylaxis and a review of the literature. J Am Acad Dermatol. 1999;40:979-987.
37. Goyal S, Huhn KM, Provost TT. Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy. Br J Dermatol. 2000;143:1087-1090.
38. Mastruserio ND, Nguyen EQ, Nielsen T, et al. Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol. 1999;41:295-298.
39. Ozbalkan Z, Calgunerim M, Onat AM, et al. Development of calciphy-laxis after long-term steroid and methotrexate use in a patient with rheumatoid arthritis. Intern Med. 2005;44:1178-1181.
40. Barri YM, Graves GS, Knochel JP. Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis. 1997;29:773-776.
41. Swanson AM, Desai SR, Jackson JD, et al. Calciphylaxis associated with chronic inflammatory conditions, immunosuppression therapy, and normal renal function: a report of 2 cases. Arch Dermatol. 2009;145:723-725.
42. Pollock B, Cunliffe WJ, Merchant WJ. Calciphylaxis in the absence of renal failure. Clin Exp Dermatol. 2000;25:389-392.
43. Riegert-Johnson DL, Kaur JS, Pfeifer EA. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin Proc. 2001;76:749-752.
44. Asobie N, Wong E, Cook MG. Calciphylaxis in a diabetic patient provoked by warfarin therapy. Clin Exp Dermatol. 2008;33:342-344.
45. Schoenfeld RJ, Grekin JN, Mehregan A. Calcium deposition in the skin: a report of four cases following electro-encephalography. Neurology. 1965;15:477-480.
46. Meissner M, Varwig D, Beier C, et al. Dystrophe Calcinosis cutis nach subkutaner Verabreichung von Para-Amino-Salizylsaure zur Behand-lung einer Lungentuberkulose. J Dtsch Dermatol Ges. 2006;4:489-491.
47. Guermazi A, Grigoryan M, Cordoliani F, et al. Unusually diffuse idio-pathic calcinosis cutis. Clin Rheumatol. 2007;26:268-270.
48. McKee PH, Liomba NG, Hutt MSR. Tumoral calcinosis: a pathological study of fifty-six cases. Br J Dermatol. 1982;107:669-674.
49. Laskin WB, Miettinen M, Fetsch JF. Calcareous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosislike lesions): clinicopathologic study of 43 cases emphasizing a pathogene-sis-based approach to classification. Am J Surg Pathol. 2007;31:15-25.
50. Slavin RE, Wen J, Kumar D, et al. Familial tumoral calcinosis. Am J Surg Pathol. 1993;17:788-802.
51. Nico MM, Bergonse FN. Subepidermal calcified nodule: report of two cases and review of the literature. Pediatr Dermatol. 2001;18:227-229.
52. Dare AJ, Axelsen RA. Scrotal calcinosis: origin from dystrophic calcification of eccrine duct milia. J Cutan Pathol. 1988;15:142-149.
53. Shah V, Shet T. Scrotal calcinosis results from calcification of cysts derived from hair follicles: a series of 20 cases evaluating the spectrum of changes resulting in scrotal calcinosis. Am J Dermatopathol. 2007;29:172-175.
54. Pabuççuollu U, Canda MS, Güray M, et al. The possible role of dartoic muscle degeneration in the pathogenesis of idiopathic scrotal calcinosis. Br J Dermatol. 2003;148:827-829.
55. Balfour PJ, Vincenti AC. Idiopathic vulvar calcinosis. Histopathology. 1991;18:183-184.
56. Cecchi R, Giomi A. Idiopathic calcinosis cutis of the penis. Dermatology. 1999;198:174-175.
57. Bécuwe C, Roth B, Villedieu MH, et al. Milia-like idiopathic calcinosis cutis. Pediatr Dermatol. 2004;21:483-485.
58. Au S, Crawford RI. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol. 2002;47:53-57.
59. Christoforou D, Strauss EJ, Abramovici L, et al. Benign extraosseous cartilage tumours of the hand and wrist. J Hand Surg Eur Vol. 2012;37:8-13.
60. Romeo S, Hogendoorn PC, Dei Tos AP. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics. Adv Anat Pathol. 2009;16:307-315.
61. Rachman R, Heffernan AH. Elastic cartilage choristoma of the neck. Plast Reconstr Surg. 1979;63:424-425.
62. O'Connell JX, Janzen DL, Hughes TR. Nuchal fibrocartilaginous pseu-dotumor: a distinctive soft-tissue lesion associated with prior neck injury. Am J Surg Pathol. 1997;21:836-840.
63. Paslin DA. Cartilaginous papule of the ear. J Cutan Pathol. 1991;18:60-63.
64. Cottoni F, Dell'Orbo C, Quacci D, et al. Primary osteoma cutis: clinical, morphological, and ultrastructural study. Am J Dermatopathol. 1993; 15:77-81.
65. Orlow SJ, Watsky KL, Bolognia JL. Skin and bones. II. J Am Acad Dermatol. 1991;25:447-462.
66. Gfesser M, Worret WI, Hein R, et al. Multiple primary osteoma cutis. Arch Dermatol. 1998;134:641-643.
67. Myllylä RM, Haapasaari KM, Palatsi R, et al. Multiple miliary osteoma cutis is a distinct disease entity: four case reports and review of the literature. Br J Dermatol. 2011;164:544-552.
68. Sanmartín O, Alegre V, Martinez-Aparicio A, et al. Congenital platelike osteoma cutis: case report and review of the literature. Pediatr Dermatol. 1993;10:182-186.
69. Stites PC, Boyd AS, Zic J. Auricular ossificans (ectopic ossification of the auricle). J Am Acad Dermatol. 2003;49:142-144.
70. Trueb RM, Panizzon RG, Burg G. Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology. 1993;186:205-209.
71. Davis MDP, Pittelkow MR, Lindor NM, et al. Progressive extensive osteoma cutis associated with dysmorphic features: a new syndrome? Case report and review of the literature. Br J Dermatol. 2002;146: 1075-1080.
72. Aynaci O, Müjgan Aynaci F, Cobanoglu U, et al. Progressive osseous heteroplasia. A case report and review of the literature. J Pediatr Orthop B. 2002;11:339-342.
73. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6:80.
74. Conlin PA, Jimenez-Quintero LP, Rapini RP. Osteomas of the skin revisited: a clinicopathologic review of 74 cases. Am J Dermatopathol. 2002;24:479-483.
75. Shoji T, Burlage AM, Bhawan J. Basal cell carcinoma with massive ossification. Am J Dermatopathol. 1999;21:34-36.
76. Al-Daraji W. Osteo-nevus of Nanta (osseous metaplasia in a benign intradermal melanocytic nevus): an uncommon phenomenon. Dermatol Online J. 2007;13:16.
77. Eccher A, Brunelli M, Gobbo S, et al. Chondroid syringoma with extensive ossification. Int J Surg Pathol. 2007;15:385-387.
78. Niimi Y, Kawana S. Desmoplastic trichoepithelioma: the association with compound nevus and ossification. Eur J Dermatol. 2002;12:90-92.
79. Jin W, Kim GY, Lee JH, et al. Intramuscular hemangioma with ossification: emphasis on sonographic findings. J Ultrasound Med. 2008;27:281-285.
80. Arsenovic NN, Sen S, Patel J, et al. Angiomatosis: a case with metaplastic ossification. Am J Dermatopathol. 2009;31:367-369.
81. Kim ES, Kim KJ, Chang SE, et al. Metaplastic ossification in a cutaneous pyogenic granuloma: a case report. J Dermatol. 2004;31:326-329.
82. Mortelé K, Lemmerling M, Defreyne L, et al. Ossified retroperitoneal malignant Schwannoma with spinal leptomeningeal metastases. Neuroradiology. 1998;40:48-50.
83. Nakamizo S, Kabashima K, Ohta M, et al. Subcutaneous ossifying lipoma with infiltration of transforming growth factor-[-producing cells. Clin Exp Dermatol. 2011;36:805-806.
84. Wilson Jones E, Heyl T. Naevus sebaceus. A report of 140 cases with special regard to the development of secondary malignant tumours. Br J Dermatol. 1970;82:99-117.
85. Kanitakis J, Disant F. Ossified cylindroma in familial cylindromatosis (Brooke Spiegler syndrome). J Cutan Patho1. 2001;28:439-440.
86. Kuo TT, Chan HL. Ossifying dermatofibroma with osteoclast-like giant cells. Am J Dermatopathol. 1994;16:193-195.
87. Moreno A, Lamarca J, Martinez R, et al. Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol. 1986;13:128-134.
88. Fletcher CD. Calcifying and ossifying soft tissue lesions presenting in the skin. J Cutan Pathol. 1996;23:297.
89. Walsh SN, Sangueza OP. Ossifying plexiform tumor: report of two new cases. Am J Dermatopathol. 2008;30:73-76.
90. Marteinsson BT, Musgrove JE. Heterotopic bone formation in abdominal incisions. Am J Surg. 1975;130:23-25.
91. Lippmann HI, Goldin RR. Subcutaneous ossification of the legs in chronic venous insufficiency. Radiology. 1960;74:279-288.
92. Yeatman JM, Varigos GA. Auricular ossification. Australas J Dermatol. 1998;39:268-270.
93. Julian CG, Bowers PW. Osteoma cutis in a lesion of solitary morphoea profunda. Clin Exp Dermatol. 2003;28:673-674.
94. Falasca GF. Metabolic diseases: gout. Clin Dermatol. 2006;24: 498-508.
95. Vanhooteghem O, Andre J, Pochet JM, et al. Occurrence of gouty tophi following acitretin therapy. Clin Exp Dermatol. 1998;23:274-276.
96. LeBoit PE, Schneider S. Gout presenting as lobular panniculitis. Am J Dermatopathol. 1987;9:334-338.
97. Niemi KM. Panniculitis of the legs with urate crystal deposition. Arch Dermatol. 1977;113:655-656.
98. Palmer DG, Highton J, Hessian PA. Development of the gout tophus. An hypothesis. Am J Clin Pathol. 1989;91:190-195.
99. Snider AA, Barsky S. Gouty panniculitis: a case report and review of the literature. Cutis. 2005;76:54-56.
100. Touart DM, Sau P. Cutaneous deposition diseases. Part I. J Am Acad Dermatol. 1998;39:149-171.
101. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45-59.
102. Fernandez-Flores A. Cutaneous amyloidosis: a concept review. Am J Dermatopathol. 2012;34:1-14
103. Masu S, Hosokawa M, Seiji M. Amyloid in localized cutaneous amy-loidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis. Acta Derm Venereol. 1981;61:381-384.
104. Apaydin R, Gürbüz Y, Bayramgürler D, et al. Cytokeratin expression in lichen amyloidosus and macular amyloidosis. J Eur Acad Dermatol Venereol. 2004;18:305-309.
105. Weedon D, Shand E. Amyloid in basal cell carcinomas. Br J Dermatol. 1979;101:141-146.
106. Malak JA, Smith EW. Secondary localized cutaneous amyloidosis. Arch Dermatol. 1962;86:465-477.
107. Jennings RC, Ahmed E. An amyloid forming nodular syringocystade-noma. Arch Dermatol. 1970;101:224-229.
108. Yang JE, Kim KM, Kang H, et al. Multiple trichoepithelioma with secondary localized amyloidosis. Br J Dermatol. 2000;143:1343-1344.
109. Zhuang L, Zhu W. Inflammatory linear verrucose epidermal nevus coexisting with lichen amyloidosus. J Dermatol. 1996;23:415-418.
110. MacDonald DM, Black MM. Secondary localized cutaneous amyloid-osis in melanocytic naevi. Br J Dermatol. 1980;103:553-556.
111. Hashimoto K, King LE. Secondary localized cutaneous amyloidosis associated with actinic keratosis. J Invest Dermatol. 1973;61:293-299.
112. Speight EL, Milne DS, Lawrence CM. Secondary localized cutaneous amyloid in Bowen's disease. Clin Exp Dermatol. 1993;18:286-288.
113. Ginarte M, León A, Toribio J. Disseminated superficial porokeratosis with amyloid deposits. Eur J Dermatol. 2005;15:298-300.
114. Hashimoto K, Kumakiri M. Colloid-amyloid bodies in PUVA-treated human psoriatic patients. J Invest Dermatol. 1979;72:70-80.
115. Romero LS, Kantor GR, Levin MW, et al. Localized cutaneous amy-loidosis associated with mycosis fungoides. J Am Acad Dermatol. 1997; 37:124-127.
116. Tsuji T, Asai Y, Hamada T. Secondary localized cutaneous amyloidosis in solar elastosis. Br J Dermatol. 1982;106:469-476.
117. Venkataram MN, Bhushnurmath SR, Muirhead DE, et al. Frictional amyloidosis: a study of 10 cases. Australas J Dermatol. 2001;42: 176-179.
118. Sidwell RU, Francis N, Roberts NM, et al. Allotropic cutaneous amy-loidosis: coincidence or progression? Clin Exp Dermatol. 2002;27: 526-528.
119. Tay CH, Dacosta JL. Lichen amyloidosis. Clinical study of 40 cases. Br J Dermatol. 1970;82:129-136.
120. Salim T, Shenoi SD, Balachandran C, et al. Lichen amyloidosus: a study of clinical, histopathologic and immunofluorescence findings in 30 cases. Indian J Dermatol Venereol Leprol. 2005;71:166-169.
121. Rajan VS, Leong YO. Macular amyloidosis. Br J Dermatol. 1971;85:300.
122. Bacharach-Buhles M, Schultz-Ehrenburg U, Altmeyer P. Perforating cutaneous amyloidosis. Hautarzt. 1992;43:364-368.
123. Chang YT, Liu HN, Wong CK, et al. Detection of Epstein-Barr virus in primary cutaneous amyloidosis. Br J Dermatol. 1997;136:823-826.
124. Teraki Y, Katsuta M, Shiohara T. Lichen amyloidosus associated with Kimura's disease: successful treatment with cyclosporine. Dermatology. 2002;204:133-135.
125. Shankar S, Russell-Jones R. Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophilia. Clin Exp Dermatol. 2004;29:363-365.
126. Weyers W, Weyers I, Bonczkowitz M, et al. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol. 1997;37:923-928.
127. Maddison B, Namazi MR, Samuel LS, et al. Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus. Br Dermatol. 2008;159:403-406.
128. Maddox JL, Goette DK. Transepithelial elimination of amyloid. Arch Dermatol. 1984;120:679-680.
129. Borrowman TA, Lutz ME, Walsh JS. Cutaneous nodular amyloidosis masquerading as a foot callus. J Am Acad Dermatol. 2003;49:307-310.
130. Mahajan D, Yadava U, Khurana N, et al. Primary localized nodular amyloidosis of the eyelid and conjunctiva: a case report. Pathology. 2006;38:189-190.
131. Clement MI, Hanovar M, Salisbury J, et al. Nodular localized primary cutaneous amyloidosis. Clin Exp Dermatol. 1987;12:460-462.
132. Ito K, Hashimoto K, Kambe N, et al. Roles of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis. J Invest Dermatol. 1987;89:415-418.
133. Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis. Review and long-term follow-up of 16 cases. Arch Dermatol. 2003;139:1157-1159.
134. Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis: a long-term follow-up study. Br J Dermatol. 2001;145:105-109.
135. Hagari Y, Michara M, Hagari S. Nodular localized cutaneous amyloidosis: detection of monoclonality of infiltrating plasma cells by polymerase chain reaction. Br J Dermatol. 1996;135:630-633.
136. Horiguchi Y, Takahashi C, Imamura S. A case of nodular cutaneous amyloidosis. Amyloid production by infiltrating plasma cells. Am J Dermatopathol. 1993;15:59-63.
137. Love WE, Miedler JD, Smith MK, et al. The spectrum of primary cutaneous nodular amyloidosis: two illustrative cases. J Am Acad Dermatol. 2008;58:S33-S35.
138. Krishnan J, Chu WS, Elrod JP, et al. Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases. Am J Clin Pathol. 1993;100:135-144.
139. Pasternak S, Wright BA, Walsh N. Soft tissue amyloidoma of the extremities. Report of a case and review of the literature. Am J Dermatopathol. 2007;29:152-155.
140. Maheshwari AV, Muro-Cacho CA, Kransdorf MJ, et al. Soft-tissue amyloidoma of the extremities: a case report and review of literature. Skeletal Radiol. 2009;38:287-292.
141. Ho MH, Chong LY. Poikiloderma-like cutaneous amyloidosis in an ethnic Chinese girl. J Dermatol. 1998;25:730-734.
142. Pacini F, Fugazzola L, Bevilacqua G, et al. Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family. J Endocrinol Invest. 1993;16:295-296.
143. Partington MW, Prentice RS. X-linked cutaneous amyloidosis: further clinical and pathological observations. Am J Med Genet. 1989;32:115-119.
144. Gamba G, Montani N, Anesi E, et al. Clotting alterations in primary systemic amyloidosis. Haematologica. 2000;85:289-292.
145. Lee DD, Huang CY, Wong CK. Dermatopathologic findings in 20 cases of systemic amyloidosis. Am J Dermatopathol. 1998;20:438-442.
146. Wheeler GE, Barrows GH. Alopecia universalis. A manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol. 1981;117:815-816.
147. Appiah YE, Onumab N, Wu H, et al. Multiple myeloma-associated amyloidosis and acral localized acquired cutis laxa. J Am Acad Dermatol. 2008;58:S32-S33.
148. Beacham BE, Greer KE, Andrews BS, et al. Bullous amyloidosis. J Am Acad Dermatol. 1980;3:506-510.
149. Alhaddab M, Srolovitz H, Rosen N. Primary systemic amyloidosis presenting as extensive cutaneous ulceration. J Cutan Med Surg. 2006;10:253-256.
150. Fujita Y, Tsuji-Abe Y, Sato-Matsumura KC, et al. Nail dystrophy and blisters as sole manifestations in myeloma-associated amyloidosis. J Am Acad Dermatol. 2006;54:712-714.
151. Buezo GF, Peñas PF, Fraga J, et al. Condyloma-like lesions as the presenting sign of multiple myeloma associated amyloidosis. Br J Dermatol. 1996;135:665-666.
152. Sibelt LA, Lokhorst HM, van de Kerkhof PCM, et al. A 'muscle' man without exercise: muscle pseudohypertrophy in myeloma-associated generalized amyloidosis. J Eur Acad Dermatol Venereol. 2007;21:986-988.
153. Magy N, Liepnieks JJ, Gil H, et al. A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis. Amyloid. 2003;10:29-33.
154. Hamidi AL, Liepnieks JJ, Hamidi AK, et al. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol. 1999;154:221-227.
155. Sepp N, Pichler E, Breathnach SM, et al. Amyloid elastosis: analysis of the role of amyloid P component. J Am Acad Dermatol. 1990;22:27-34.
156. Haas N, Küster W, Zuberbier T, et al. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004;151:99-104.
157. Anders EM, McAdam KP, Anders RF. Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy. Clin Exp Immunol. 1977;27:111-117.
158. Anand S, Singh R, Aurora AL, et al. Systemic amyloidosis in psoriasis, lepromatous leprosy & cutaneous tuberculosis. Indian J Dermatol. 1976;21:45-51.
159. Claes K, Bammens B, Delforge M, et al. Another devastating complication of the Schnitzler syndrome: AA amyloidosis. Br J Dermatol. 2008;158:182-184.
160. Powell AM, Albert S, Bhogal B, et al. Discoid lupus erythematosus with secondary amyloidosis. Br J Dermatol. 2005;153:746-749.
161. Yi S, Naito M, Takahashi K, et al. Complicating systemic amyloidosis in dystrophic epidermolysis bullosa, recessive type. Pathology. 1988; 20:184-187.
162. Brownstein MH, Helwig EB. The cutaneous amyloidoses. II. Systemic forms. Arch Dermatol. 1970;102:20-28.
163. Elder GH. Metabolic abnormalities in the porphyrias. Semin Dermatol. 1986;5:88-98.
164. Thiers BH. The porphyrias. J Am Acad Dermatol. 1981;5:621-625.
165. Weedon D. Metabolic and storage diseases. In: Weedon D, ed. Weedonis Skin Pathology. China: Elsevier; 2010:482-498.
166. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375:924-937.
167. Santoro FA, Lim HW. Update on photodermatoses. Semin Cutan Med Surg. 2011;30:229-238.
168. Kaufman BM, Vickers HR, Rayne J, et al. Congenital erythropoietic porphyria. Br J Dermatol. 1967;79:210-220.
169. Doss M. Enzymatic deficiencies in acute hepatic porphyrias: porphobilinogen synthase deficiency. Semin Dermatol. 1986;5:161-168.
170. Meola T, Lim HW. The porphyrias. Dermatol Clin. 1993;11:583-596.
171. Poh-Fitzpatrick MB. Porphyrin-sensitized cutaneous photosensitivity. Pathogenesis and treatment. Clin Dermatol. 1985;3:41-82.
172. Corey TJ, DeLeo VA, Christianson H, et al. Variegate porphyria. Clinical and laboratory features. J Am Acad Dermatol. 1980;2:36-43.
173. Pimstone NR. Porphyria cutanea tarda. Semin Liver Dis. 1982;2:132-142.
174. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, et al. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med. 1979;67:277-286.
175. Conry-Cantilena C, Vilamidou L, Melpolder JC, et al. Porphyria cutanea tarda in hepatitis C virus-infected blood donors. J Am Acad Dermatol. 1995;32:512-514.
176. Kim JJ, Lim HW. Hexachlorobenzene and porphyria cutanea tarda. Arch Dermatol. 1999;135:459-460.
177. Todd DJ. Erythropoietic protoporphyria Br J Dermatol. 1994;131:751-766.
178. Armstrong DKB, Sharpe PC, Chambers CR, et al. Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern. Br J Dermatol. 2004;151:920-923.
179. Perrot H, Germain D, Euvrard S, et al. Porphyria cutanea tarda-like dermatosis by hemodialysis: ultrastructural study of exposed skin. Arch Dermatol Res. 1977;259:177-185.
180. Harvey E, Bell H, Paller AS, et al. Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. J Pediatr. 1992;121:749-752.
181. Oh C, Jones B, Solomon R, et al. Pseudoporphyria secondary to narrowband UVB phototherapy for psoriasis. Australas J Dermatol. 2006; 47:134-136.
182. Egbert BM, LeBoit PE, McCalmont T, et al. Caterpillar bodies: distinctive, basement membrane-containing structures in blisters of porphyria. Am J Dermatopathol. 1993;15:199-202.
183. Cormane RH, Szabo E, Hoo TT. Histopathology of the skin in acquired and hereditary porphyria cutanea tarda. Br J Dermatol. 1971;85:531-539.
184. Dabski C, Beutner EH. Studies of laminin and type IV collagen in blisters of porphyria cutanea tarda and drug-induced pseudoporphyria. J Am Acad Dermatol. 1991;25:28-32.
185. Ahmed AR. Diagnosis of bullous disease and studies in the pathogenesis of blister formation using immunopathological techniques. J Cutan Pathol. 1984;11:237-248.
186. Maynard B, Peters MS. Histologic and immunofluorescence study of cutaneous porphyrias. J Cutan Pathol. 1992;19:40-47.
187. Raso DS, Greene WB, Maize JC, et al. Caterpillar bodies of porphyria cutanea tarda ultrastructurally represent a unique arrangement of colloid and basement membrane bodies. Am JDermatopathol. 1996;18:24-29.
188. Urbach E, Wieth C. Lipoidosis cutis et mucosae. Virchows Arch [Pathol Anat]. 1929;273:285-319.
189. Heyl T. Lipoid proteinosis I: the clinical picture. Br J Dermatol. 1963; 75:465-472.
190. Sainani MP, Muralidhar R, Parthiban K, et al. Lipoid proteinosis of Urbach and Weithe: case report and a brief review of the literature. Int Ophthalmol. 2011;31:141-143.
191. Callizo M, Ibáñez-Flores N, Laue J, et al. Eyelid lesions in lipoid proteinosis or Urbach-Wiethe disease: case report and review of the literature. Orbit. 2011;30:242-244.
192. Findlay G, Scott F, Cripps D. Porphyria and lipoid proteinosis: a clinical, histological and biochemical comparison of 19 South African cases. Br J Dermatol. 1966;78:69-80.
193. Piérard GE, van Cauwenberge D, Budo J, et al. A clinicopathologic study of six cases of lipoid proteinosis. Am J Dermatopathol. 1988;10: 300-305.
194. Harper JI, Filipe MI, Staughton RCD. Lipoid proteinosis: variations in the histochemical characteristics. Clin Exp Dermatol. 1983;8:135-141.
195. Mehregan D, Hooten J. Adult colloid milium: a case report and literature review. Int J Dermatol. 2011;50:1531-1534.
196. Chowdhury MM, Blackford S, Williams S. Juvenile colloid milium associated with ligneous conjunctivitis: report of a case and review of the literature. Clin Exp Dermatol. 2000;25:138-140.
197. Dupre A, Bonafe JF, Pieraggi MT, et al. Paracolloid of the skin. J Cutan Pathol. 1979;6:304-309.
198. Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93:613-622.
199. Saeed S, Sagatys E, Morgan MB. Acral keratosis with eosinophilic dermal deposits: a distinctive clinicopathologic entity or colloid milium redux? J Cutan Pathol. 2006;33:679-685.
200. Pourrabbani S, Marra DE, Iwasaki J, et al. Colloid milium: a review and update. J Drugs Dermatol. 2007;6:293-296.
201. Handfield-Jones SE, Atherton DJ, Black MM, et al. Juvenile colloid milium: clinical, histological and ultrastructural features. J Cutan Pathol. 1992;19:434-438.
202. Hashimoto K, Miller F, Bereston ES. Colloid milium. Histochemical and electron microscopic studies. Arch Dermatol. 1972;105:684-694.
203. Weedon D, Gutteridge BH, Hockly RG, et al. Unusual cutaneous reactions to injections of corticosteroids. Am J Dermatopathol. 1982; 4:199-203.
204. Philipsen HP, Reichart PA. Pulse or hyaline ring granuloma. Review of the literature on etiopathogenesis of oral and extraoral lesions. Clin Oral Invest. 2010;14:121-128.
205. Cerroni L, Borroni RG, Massone C, et al. "Ancient" blue nevi (cellular blue nevi with degenerative stromal changes). Am J Dermatopathol. 2008;30:1-5.
206. Urbina F, Sazunic I, Murray G. Infantile systemic hyalinosis or juvenile hyaline fibromatosis? Pediatr Dermatol. 2004;21:154-159.
207. Miyake I, Tokumaru H, Sugino H, et al. Juvenile hyaline fibromatosis. Case report with five years' follow-up. Am J Dermatopathol. 1995;17: 584-590.
208. Ebner H, Gebhart W. Light and electron microscopic studies on colloid and other cytoid bodies. Clin Exp Dermatol. 1977;2:311-322.
209. Gertz MA. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am JHematol. 2012;87:503-510.
210. Niemi K-M, Stenman S, Borgström GH, et al. Massive cutaneous hyalinosis. A newly recognized disease. Arch Dermatol. 1980; 116: 580-583.
211. Virchow R. Ein Fall von allegemeiner ochronose der knorpel aud knor-pelahnlichen theile. Virchows Arch (Pathol Anat). 1866;37.
212. Pick L. Uber die ochronosis klin. Wochenschr. 1906;43:478-480.
213. Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q J Med. 1912;5:505-507.
214. Katsambas AD, Stratigos AJ. Depigmenting and bleaching agents: coping with hyperpigmentation. Clin Dermatol. 2001;19:483-488.
215. Tuffanelli D, Abraham RK, Dubois EI. Pigmentation from antimalarial therapy. Arch Dermatol. 1963;88:419-426.
216. Tan SK. Exogenous ochronosis-a diagnostic challenge. J Cosmet Dermatol. 2010;9:313-317.
217. Hoshaw RA, Zimmerman KG, Menter A. Ochronosis-like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121:105-108.
218. Bongiorno MR, Aricò M. Exogenous ochronosis and striae atrophicae following the use of bleaching creams. Int J Dermatol. 2005;44:112-115.
219. Lichtenstein L, Kaplan L. Hereditary ochronosis; pathologic changes observed in two necropsied cases. Am J Pathol. 1954;30:99-125.
220. Phillips JI, Isaacson C, Carman H. Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol. 1986;8:14-21.
221. Jordaan HF, van Niekerk DJ. Transepidermal elimination in exogenous ochronosis. A report of two cases. Am J Dermatopathol. 1991;13:41 8-424.
222. Jordaan HF, Mulligan RP. Actinic granuloma-like change in exogenous ochronosis: case report. J Cutan Pathol. 1990;17:236-240.
223. Milder MS, Cook SD, Stray S, et al. Idiopathic hemochromatosis. Medicine. 1980;59:34-49.
224. Köstler E, Porst H, Wollina U. Cutaneous manifestations of metabolic diseases: uncommon presentations. Clin Dermatol. 2005;23:457-464.
225. Cawley EP, Hsu YT, Wood BT, et al. Hemochromatosis and the skin. Arch Dermatol. 1969;100:1-6.
226. Perdrup A, Poulsen H. Hemochromatosis and vitiligo. Arch Dermatol. 1964;90:34-37.
227. Falanga V, Zheng P, Lavker RM. Ultrastructural study of iron deposition in the eccrine sweat glands of patients with iron overload. Br J Dermatol. 1984;110:51-56.
228. Chevrant-Breton J, Simon M, Bourel M, et al. Cutaneous manifestations of idiopathic hemochromatosis. Study of 100 cases. Arch Dermatol. 1977;113:161-165.
229. Gochee PA, Lawrie W. What's new in hemochromatosis. Curr Opin Hematol. 2001;8:98-104.
230. Weintraub LR, Demis DJ, Conrad ME, et al. Iron excretion by the skin. Selective localization of iron59 in epithelial cells. Am J Pathol. 1965; 46:121-127.
231. Olmstead PM, Lund HZ, Leonard DD. Monsel's solution: a histologic nuisance. J Am Acad Dermatol. 1980;3:492-498.
232. Amazon K, Robinson MJ, Rywlin AM. Ferrugination caused by Monsel's solution. Am J Dermatopathol. 1980;2:197-205.
233. Hanau D, Grosshans E. Monsel's solution and histological lesions. Am J Dermatopathol. 1981;3:418-419.
234. Goldstein N. IV. Complications from tattoos. J Dermatol Surg Oncol. 1979;5:869-878.
235. Goldstein AP. VII. Histologic reactions in tattoos. J Dermatol Surg Oncol. 1979;5:896-900.
236. Mortimer NJ, Chave TA, Johnson GA. Red tattoo reactions. Clin Exp Dermatol. 2003;28:508-510.
237. Morales-Callaghan AM Jr, Aguilar-Bernier M, Martínez-Garcia G, et al. Sarcoid granuloma on black tattoo. J Am Acad Dermatol. 2006;55: S71-S73.
238. Bagwan IN, Walker M, Theaker JM. Granuloma annulare-like tattoo reaction. J Cutan Pathol. 2007;34:804-805.
239. Bethune GC, Miller RA, Murray SJ, et al. A novel inflammatory reaction in a tattoo: challenge. Am J Dermatopathol. 2011;33:740-741; 749.
240. Sweeney SA, Hicks LD, Ranallo N, et al. Perforating granulomatous dermatitis reaction to exogenous tattoo pigment: a case report and review of the literature. Am J Dermatopathol. 2011 September 13. [Epub ahead of print].
241. Kluger N, Jolly M, Guillot B. Tattoo-induced vasculitis. J Eur Acad Dermatol Venereol. 2008;22:643-644.
242. Blumental G, Okun MR, Ponitch JA. Pseudolymphomatous reaction to tattoos. J Am Acad Dermatol. 1982;6:485-488.
243. Granstein RD, Sober AJ. Drug-and heavy metal-induced hyperpigmentation. J Am Acad Dermatol. 1981;5:1-18.
244. Tajirian AL, Campbell RM, Robinson-Bostom L. Localized argyria after exposure to aerosolized solder. Cutis. 2006;78:305-308.
245. Buckley WR. Localized argyria. Arch Dermatol. 1963;88:531-539.
246. Fisher NM, Marsh E, Lazova R. Scar-localized argyria secondary to silver sulfadiazine cream. J Am Acad Dermatol. 2003;49:730-732.
247. Suzuki H, Baba S, Uchigasaki S, et al. Localized argyria with chrysiasis caused by implanted acupuncture needles. J Am Acad Dermatol. 1993; 29:833-837.
248. Takeishi E, Hirose R, Hamasaki Y, et al. Localized argyria 20-years after embedding of acupuncture needles. Eur J Dermatol. 2002;12:609-611.
249. Kakurai M, Demitsu T, Umemoto N, et al. Activation of mast cells by silver particles in a patient with localized argyria due to implantation of acupuncture needles. Br J Dermatol. 2003;148:822.
250. Morton CA, Fallowfield M, Kemmett D. Localized argyria caused by silver earrings. Br J Dermatol. 1996;135:484-485.
251. Brandt D, Park B, Hoang M, et al. Argyria secondary to ingestion of home-made silver solution. J Am Acad Dermatol. 2005;53:S105-S107.
252. Robinson-Bostom L, Pomerantz D, Wilkel C, et al. Localized argyria with pseudo-ochronosis. J Am Acad Dermatol. 2002;46:222-227.
253. Cox AJ, Marich KW. Gold in the dermis following gold therapy for rheumatoid arthritis. Arch Dermatol. 1973;108:655-657.
254. Smith RW, Leppard B, Barnett NL, et al. Chrysiasis revisited: a clinical and pathological study. Br J Dermatol. 1995;133:671-678.
255. Penneys NS. Gold therapy: dermatologic uses and toxicities. J Am Acad Dermatol. 1979;1:315-320.
256. Cascos A. Etude comparative des pigmentations metallique, argyrose et chryose. Ann Dermatol Venereol. 1936;7:751-762.
257. Al-Talib RK, Wright DH, Theaker JM. Orange-red birefringence of gold particles in paraffin wax embedded sections: an aid to the diagnosis of chrysiasis. Histopathology. 1994;24:176-178.
258. Larsen FS, Bøye H, Hage E. Chrysiasis: electron microscopic studies and X-ray microanalysis. Clin Exp Dermatol. 1984;9:174-180.
259. Guillard O, Fauconneau B, Pineau A, et al. Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma. J Trace Elem Med Biol. 2012 March 14. [Epub ahead of print].
260. Akyol A, Boyvat A, Kundakçi N. Contact sensitivity to aluminum. Int J Dermatol. 2004;43:942-943.
261. Cosnes A, Flechet ML, Revuz J. Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis. 1990;23:65-67.
262. Maubec E, Pinquier L, Viguier M, et al. Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol. 2005;52:623-629.
263. Hernández I, Sanmartín O, Cardá C, et al. B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy. Actas Dermosifiliogr. 2008;99:213-216.
264. Del Rosario RN, Barr RJ, Graham BS, et al. Exogenous and endogenous cutaneous anomalies and curiosities. Am J Dermatopathol. 2005; 27:259-267.
265. McFadden N, Lyberg T, Hensten-Pettersen A. Aluminum-induced gran-ulomas in a tattoo. J Am Acad Dermatol. 1989;20:903-908.
266. Martín JM, Nagore E, Cremades A, et al. An amalgam tattoo on the oral mucosa related to a dental prosthesis. J Eur Acad Dermatol Venereol. 2005;19:90-92.
267. Richtig E, Leinweber B, Ghanimi Y, et al. Speckled posttraumatic hyperpigmentation by foreign bodies on the lower legs after welding. Arch Dermatol. 2006;142:790-792.
268. Slater DN, Underwood JCE, Durrant TE, et al. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray micro-analysis. Br J Dermatol. 1982;107:103-108.
269. Mowry RG, Sams WM Jr, Caufield JB. Cutaneous silica granuloma. Arch Dermatol. 1991;127:692-694.
270. Walsh NM, Hanly JG, Tremaine R, et al. Cutaneous sarcoidosis and foreign bodies. Am J Dermatopathol. 1993;15:203-207.
271. Shelley WB, Hurley HJ. The pathogenesis of silica granulomas in man: a non-allergic colloidal phenomenon. J Invest Dermatol. 1960; 34:107-123.
272. Curtis GH. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol. 1951;54:470-482.
273. Berlin JM, Taylor JS, Sigel JE, et al. Beryllium dermatitis. J Am Acad Dermatol. 2003;49:939-941.
274. Shelley WB, Hurley HJ. Allergic origin of zirconim deodorant granu-loma. Br J Dermatol. 1958;70:75-101.
275. Skelton HG III, Smith KJ, Johnson FB, et al. Zirconium granuloma resulting from an aluminum zirconium complex: a previously unrecognized agent in development of hypersensitivity granulomas. J Am Acad Dermatol. 1993;28:874-876.
276. Lueth HC, Sutton DC, McMullen CJ. Generalized discoloration of skin resembling argyria following prolonged oral use of bismuth: a case of "bismuthia." Arch Intern Med. 1936;57:1115-1124.
277. Dijkstra JWE, Bergfeld WF, Taylor JS, et al. Prurigo pigmentosa A persistent lichenoid reaction to bismuth? Int J Dermatol. 1987;26:379-381.
278. Viraben R, Boulinguez S, Alba C. Granulomatous dermatitis after implantation of a titanium containing pacemaker. Contact Dermatitis. 1995;33:437.
279. Abdallah HI, Balsara RK, O'Riordan AC. Pacemaker contact sensitivity: clinical recognition and management. Ann ThoracSurg. 1994;57:1017-1018.
280. High WA, Ayers RA, Adams JR, et al. Granulomatous reaction to titanium alloy: an unusual reaction to ear piercing. J Am Acad Dermatol. 2006;55:716-720.
281. Akimoto M, Hara H, Suzuki H. Metallosis of the skin mimicking malignant skin tumour. Br J Dermatol. 2003;149:653.
282. Dupre A, Touron P, Daste J, et al. Titanium pigmentation. An electron probe microanalysis study. Arch Dermatol. 1985;121:656-658.
283. Moran CA, Mullick FG, Ishak KG, et al. Identification of titanium in human tissues: probable role in pathologic processes. Hum Pathol. 1991;22:450-454.
284. Greenberg JE, Lynn M, Kirsner RS, et al. Mucocutaneous pigmented macule as aresult of zinc deposition. J Cutan Pathol. 2002;29:613-615.
285. Lamar LM, Bliss BO. Localized pigmentation of the skin due to topical mercury. Arch Dermatol. 1966;93:450-453.
286. Burge KM, Winkelmann RK. Mercury pigmentation: an electron microscopic study. Arch Dermatol. 1970;102:51-61.
287. Rachman R. Soft-tissue injury by mercury from a broken thermometer. A case report and review of the literature. Am J Clin Pathol. 1974;61:296-300.
288. Rogers M, Goodhew P, Szafraniec T, et al. Mercury exanthem. Australas J Dermatol. 1986;27:70-75.
289. Tschanz C, Prins C. Drug rash with eosinophilia and systemic symptoms caused by topical application of mercury. Dermatology. 2000;201:381-382.
290. Dinehart SM, Dillard R, Raimer SS, et al. Cutaneous manifestations of acrodynia (Pink disease). Arch Dermatol. 1988;124:107-109.
291. Dantzig PI. A new cutaneous sign of mercury poisoning? J Am Acad Dermatol. 2003;49:1109-1111.
292. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2:253-262.
293. Dubois EL. Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum. 1978;8:33-51.
294. Koranda FC. Antimalarials. J Am Acad Dermatol. 1981;4:650-657.
295. Ribrioux A. Synthetic antimalarials and skin. Ann Dermatol Venereol 1990;117:975-990.
296. Bahadir S, Apaydn R, Çobanoilu Ü, et al. Amiodarone pigmentation, eye and thyroid alterations. J Eur Acad Dermatol Venereol. 2000;14:194-195.
297. Rappersberger K, Honigsmann H, Ortel B, et al. Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery. J Invest Dermatol. 1989;93:201-209.
298. Delage C, Lagace R, Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J. 1975;112:1205-1208.
299. Ammoury A, Michaud S, Paul C, et al. Photodistribution of blue-gray hyperpigmentation after amiodarone treatment. Molecular characterization of amiodarone in the skin. Arch Dermatol. 2008;144:92-96.
300. Wolf ME, Richer S, Berk MA, et al. Cutaneous and ocular changes associated with the use of chlorpromazine. Int J Clin Pharmacol Ther Toxicol. 1993;31:365-367.
301. Angel TA, Stalkup JR, Hsu S. Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use. Int J Dermatol. 2002;41:327-329.
302. Narurkar V, Smoller BR, Hu CH, et al. Desipramine-induced blue-gray photosensitive pigmentation. Arch Dermatol. 1993;129:474-476.
303. Mars U, Larsson BS. Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res. 1999;12:266-274.
304. Basler RSW, Taylor WB, Peacor DR. Postacne osteoma cutis. X-ray diffraction analysis. Arch Dermatol. 1974;110:113-114.
305. Hawfield W, Goodrich R, Warren S, et al. Trauma-induced cutaneous pigmentation from tetracycline: a case report. Pediatr Dermatol. 2004; 21:164-166.
306. Böhm M, Schmidt PF, Lödding B, et al. Cutaneous hyperpigmentation induced by doxycycline. Histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence. Am JDermatopathol. 2002;24:345-350.
307. Eisen D, Hakim MD. Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf. 1998;18:431-440.
308. Fenske N, Millns J, Greer K. Minocycline-induced pigmentation at sites of cutaneous inflammation. JAMA. 1980;244:1103-1106.
309. Simons J, Morales A. Minocycline and general cutaneous pigmentation. J Am Acad Dermatol. 1980;3:244-247.
310. Mehrany K, Kist JM, Ahmed DD, et al. Minocycline-induced cutaneous pigmentation. Int J Dermatol. 2003;42:551-552.
311. Pepine M, Flowers FP, Ramos-Caro FA. Extensive cutaneous hyper-pigmentation caused by minocycline. J Am Acad Dermatol. 1993;28: 292-295.
312. Sato S, Murphy GF, Bernhard JD, et al. Ultrastructural and X-ray microanalytical observations of minocycline-related hyperpigmentation of the skin. J Invest Dermatol. 1981;77:264-271.
313. Kossard S, Doherty E, McColl I, et al. Autofluorescence of clofazimine in discoid lupus erythematosus. J Am Acad Dermatol. 1987;17: 867-871.
314. Mowad CM, Nguyen TV, Elenitsas R, et al. Bleomycin-induced flagellate dermatitis: a clinical and histopathological review. Br J Dermatol. 1994;131:700-702.
315. Tsuji T, Sawabe M. Hyperpigmentation in striae distensae after bleomycin treatment. J Am Acad Dermatol. 1993;28:503-505.
316. Schrijvers D, Van Den Brande J, Vermorken JB. Supravenous discoloration of the skin due to docetaxel treatment. Br J Dermatol. 2000;142: 1069-1070.
317. von Hilsheimer GE, Norton SA. Delayed bleomycin-induced hyperpigmentation and pressure on the skin. J Am Acad Dermatol. 2002;46:642-643.
318. Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64:1-34.
319. Barr RJ, Stegman SJ. Delayed skin test reaction to injectable collagen implant (Zyderm). J Am Acad Dermatol. 1984;10:652-658.
320. Barr RJ, King DF, McDonald RM, et al. Necrobiotic granulomas associated with bovine collagen test site injections. J Am Acad Dermatol. 1982;6:867-869.
321. McCoy JP Jr, Schade WJ, Siegle RJ, et al. Characterization of the humoral immune response to bovine collagen implants. Arch Dermatol. 1985;121:990-994.
322. García-Domingo MI, Alijotas Rey J, Cistero-Bahima A, et al. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Investig Allergol Clin Immunol. 2000;10: 107-109.
323. Sclafani A, Romo T, Jacono AA, et al. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation: clinical observations and histologic findings. Arch Facial Plast Surg. 2000;2:130-136.
324. Moody BR, Sengelmann RD. Self-limited adverse reaction to human-derived collagen injectable product. Dermatol Surg. 2000;26:936-938.
325. Ghislanzoni M, Bianchi F, Barbareschi M, et al. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol. 2006; 154:755-758.
326. Dadzie OE, Mahalingam M, Parada M, et al. Adverse reactions to soft tissue fillers-a review of the histological features. J Cutan Pathol. 2008; 35:536-548.
327. Okada S, Okuyama R, Tagami H, et al. Eosinophilic granulomatous reaction after intradermal injection of hyaluronic acid. Acta Derm Venereol 2008;88:69-70.
328. Fernandez Aceñero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg. 2003;29:1225-1226.
329. Moulonguet I, de Goursac V, Plantier F. Granulomatous reaction after injection of a new resorbable filler Novabel. Am J Dermatopathol 2011;33:710-711.
330. Schuller-Petrovic S, Pavlovic MD, Schuller SS, et al. Early granulomatous foreign body reactions to a novel alginate dermal filler: the system's failure? J Eur Acad Dermatol Venereol. 2011 September 20. doi: 10.1111/j.1468-3083.2011. 04264.x. [Epub ahead of print].
331. Massone C, Horn M, Kerl H, et al. Foreign body granuloma due to Matridex injection for cosmetic purposes. Am J Dermatopathol. 2009; 31:197-199.
332. Dijkema SJ, van der Lei B, Kibbelaar RE. New-fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg. 2005;115:76e-78e.
333. Darsow U, Bruckbauer H, Worret WI, et al. Subcutaneous oleomas induced by self-injection of sesame seed oil for muscle augmentation. J Am Acad Dermatol. 2000;42:292-294.
334. Claudy A, Garcier F, Schmitt D. Sclerosing lipogranuloma of the male genitalia: ultrastructural study. Br J Dermatol. 1981;105:451-455.
335. Morgan AM. Localized reactions to injected therapeutic materials. Part 2. Surgical agents. J Cutan Pathol. 1995;22:289-303.
336. Zimmermann US, Clerici TJ. The histological aspects of fillers complications. Semin Cutan Med Surg. 2004;23:241-250.
337. Rudolph CM, Soyer HP, Schuller-Petrovic S, et al. Foreign body gran-ulomas due to injectable aesthetic microimplants. Am J Surg Pathol. 1999;23:113-117.
338. Rosa SC, de Magalhães AV, de Macedo JL. An experimental study of tissue reaction to polymethyl methacrylate (PMMA) microspheres (Artecoll) and dimethylsiloxane (DMS) in the mouse. Am J Dermato-pathol. 2008;30:222-227.
339. Requena C, Izquierdo MJ, Navarro M, et al. Adverse reactions to inject-able aesthetic microimplants. Am J Dermatopathol. 2001;23:197-202.
340. Christensen L, Breiting V, Vuust J, et al. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aqua-mid): causes and treatment. Eur J Plast Surg. 2006;28:464-471.
341. Gómez-de la Fuente E, Alvarez-Fernández JG, Pinedo F, et al. Reacción cutánea tras implante con Bio-Alcamid. Actas Dermosifiliogr. 2007;98: 271-275.
342. Blackmon JA, Jeffy BG, Malone JC, et al. Oxalosis involving the skin: case report and literature review. Arch Dermatol. 2011;147:1302-1305.
343. Rankin AC, Walsh SB, Summers SA, et al. Acute oxalate nephropathy causing late renal transplant dysfunction due to enteric hyperoxaluria. Am J Transplant. 2008;8:1755-1758.
344. Bogle MA, Teller CF, Tschen JA, et al. Primary hyperoxaluria in a 27-year-old woman. J Am Acad Dermatol. 2003;49:725-728.
345. Somach SC, Davis BR, Paras FA, et al. Fatal cutaneous necrosis mimicking calciphylaxis in a patient with type 1 primary hyperoxaluria. Arch Dermatol. 1995;131:821-823.
346. Ohtake N, Uchiyama H, Furue M, et al. Secondary cutaneous oxalosis: cutaneous deposition of calcium oxalate dihydrate after long-term hemodialysis. J Am Acad Dermatol. 1994;31:368-372.
347. Sertoli A, Giorgini S, Farli M. Fiberglass dermatitis. Clin Dermatol. 1992;10:167-174.
348. Sulzberger MB, Baer RL. The effects of fiber glass on animal and human skin. Ind Med Surg. 1942;11:482-484.
349. Fisher BK, Warkentin JD. Fiber glass dermatitis. Arch Dermatol. 1969; 99:717-719.
350. Kyriakos M. Myospherulosis of the paranasal sinuses, nose and middle ear. Am J Clin Pathol. 1977;67:118-130.
351. Rosai J. The nature of myospherulosis of the upper respiratory tract. Am J Clin Pathol. 1978;69:475-481.
352. Travis WD, Li CY, Weiland LH. Immunostaining for hemoglobin in two cases of myospherulosis. Arch Pathol Lab Med. 1986;110: 763-765.
353. Waldman JS, Barr RJ, Espinoza FP. Subcutaneous myospherulosis. J Am Acad Dermatol. 1989;21:400-403.
354. Lazarov A, Avinoach I, Giryes H, et al. Dermal spherulosis (myospher-ulosis) after topical treatment for psoriasis. J Am Acad Dermatol. 1994; 30:265-267.
355. Henry CR, Nace M, Helm KF. Collagenous spherulosis in an oral mucous cyst. J Cutan Pathol. 2008;35:428-430.
356. Kuo T, Hu S, Huang C, et al. Cutaneous involvement in polyvinyl-pyrrolidone disease. A clinicopathologic study of five patients including two patients with severe anemia. Am J Surg Pathol. 1997;21: 1361-1367.
357. Chi C, Wang SH, Kuo TT. Localized cutaneous polyvinylpyrrolidone storage disease mimicking cheilitis granulomatosa. J Cutan Pathol. 2006;33:454-457.
358. Dupont A, Lachapelle JM. Dermite due a un depot medidicamenteux au cours du traitement d'un diabete insipide. Bull Soc Fr Dermatol Syphiligr. 1964;71:508-509.
359. Mensing H, Koster W, Schaeg G, et al. Zur klinischen Varianz der Polyvinylpyrrolidon-Dermatose. Z Hautkr. 1984;59:1027-1037.
360. Kuo T, Hsueh S. Mucicarminophilic histiocytosis. A polyvinylpyrroli-done (PVP) storage disease simulating signet-ring cell carcinoma. Am J Surg Pathol. 1984;8:419-428.